Thomas M. Kollmeyer

5.9k total citations · 1 hit paper
29 papers, 1.1k citations indexed

About

Thomas M. Kollmeyer is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Thomas M. Kollmeyer has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 14 papers in Cancer Research and 12 papers in Molecular Biology. Recurrent topics in Thomas M. Kollmeyer's work include Glioma Diagnosis and Treatment (16 papers), MicroRNA in disease regulation (6 papers) and Prostate Cancer Treatment and Research (5 papers). Thomas M. Kollmeyer is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), MicroRNA in disease regulation (6 papers) and Prostate Cancer Treatment and Research (5 papers). Thomas M. Kollmeyer collaborates with scholars based in United States, Canada and Sweden. Thomas M. Kollmeyer's co-authors include Robert B. Jenkins, Karla V. Ballman, Yuan‐Ping Pang, George G. Klee, Eric J. Bergstralh, Stephanie Fink, Ismael A. Vergara, Mercedeh Ghadessi, R. Jeffrey Karnes and Timothy J. Triche and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Thomas M. Kollmeyer

27 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

2013 427 citations Nicholas Erho, Anamaria Crisan et al. PLoS ONE profile →

Peers

Thomas M. Kollmeyer

PRM

GENET

ONCOL

David Cerna United States

Marie Will United States

Jonas Cicenas Switzerland

Nicolas Borisov Russia

Christine Stephan Switzerland

Mikhail Akimov Russia

Andreyan N. Osipov Russia

Wenqing Qi United States

Charles Karan United States

Ana Bosch Sweden

David Cerna United States

Thomas M. Kollmeyer

750 ×1.5

157 ×0.3

PRM

250 ×0.6

166 ×0.8

GENET

297 ×2.5

ONCOL

Citations per year, relative to Thomas M. Kollmeyer Thomas M. Kollmeyer (= 1×) peers David Cerna

Countries citing papers authored by Thomas M. Kollmeyer

Since Specialization

Citations

This map shows the geographic impact of Thomas M. Kollmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Kollmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Kollmeyer more than expected).

Fields of papers citing papers by Thomas M. Kollmeyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Kollmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Kollmeyer. The network helps show where Thomas M. Kollmeyer may publish in the future.

Co-authorship network of co-authors of Thomas M. Kollmeyer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Kollmeyer. A scholar is included among the top collaborators of Thomas M. Kollmeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Kollmeyer. Thomas M. Kollmeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ida, Cristiane M., Thomas M. Kollmeyer, Rachael A. Vaubel, et al.. (2024). Histopathologic and molecular profile of gliomas diagnosed in Lagos, Nigeria. Neuro-Oncology Practice. 11(6). 753–762.

Panda, Arijit, Milovan Šuvakov, Jessica Mariani, et al.. (2023). Clonally Selected Lines After CRISPR-Cas Editing Are Not Isogenic. The CRISPR Journal. 6(2). 176–182. 4 indexed citations

Eckel‐Passow, Jeanette E., Daniel H. Lachance, Paul A. Decker, et al.. (2022). Inherited genetics of adult diffuse glioma and polygenic risk scores—a review. Neuro-Oncology Practice. 9(4). 259–270. 3 indexed citations

Kollmeyer, Thomas M., Corinne Praska, Caterina Giannini, et al.. (2020). Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomas. Neuro-Oncology Advances. 2(1). vdaa109–vdaa109. 28 indexed citations

Kohlmann, Wendy, Thomas M. Kollmeyer, Robert B. Jenkins, et al.. (2019). The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database. BMC Cancer. 19(1). 190–190. 3 indexed citations

Ida, Cristiane M., Derek R. Johnson, Thomas M. Kollmeyer, et al.. (2019). RARE-32. POLYMORPHOUS LOW-GRADE NEUROEPITHELIAL TUMOR OF THE YOUNG (PLNTY): GENETIC ANALYSIS CONFIRMS FREQUENT MAPK PATHWAY ACTIVATION. Neuro-Oncology. 21(Supplement_6). vi228–vi228.

Vaubel, Rachael A., Thomas M. Kollmeyer, Alissa Caron, et al.. (2017). Synchronous gemistocytic astrocytoma IDH-mutant and oligodendroglioma IDH-mutant and 1p/19q-codeleted in a patient with CCDC26 polymorphism. Acta Neuropathologica. 134(2). 317–319. 3 indexed citations

Praska, Corinne, Georgina Armstrong, Thomas M. Kollmeyer, et al.. (2017). Molecular subtyping of tumors from patients with familial glioma. Neuro-Oncology. 20(6). 810–817. 7 indexed citations

Eckel‐Passow, Jeanette E., Paul A. Decker, Edward G. Hughes, et al.. (2017). PATH-47. CLINICAL SENSITIVITY AND SPECIFICITY OF ILLUMINA METHYLATION ARRAY FOR CLASSIFYING ADULT GLIOMAS INTO WHO GROUPS. Neuro-Oncology. 19(suppl_6). vi181–vi181. 3 indexed citations

10.

Holdhoff, Matthias, Gregory Cairncross, Thomas M. Kollmeyer, et al.. (2017). Genetic landscape of extreme responders with anaplastic oligodendroglioma. Oncotarget. 8(22). 35523–35531. 8 indexed citations

11.

Erho, Nicholas, Anamaria Crisan, Ismael A. Vergara, et al.. (2013). Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy. PLoS ONE. 8(6). e66855–e66855. 427 indexed citations breakdown →

12.

Jenkins, Robert B., Margaret Wrensch, Derek R. Johnson, et al.. (2011). Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genetics. 204(1). 13–18. 44 indexed citations

13.

Bender, Aaron M., Lara S. Collier, Fausto J. Rodríguez, et al.. (2010). Sleeping Beauty –Mediated Somatic Mutagenesis Implicates CSF1 in the Formation of High-Grade Astrocytomas. Cancer Research. 70(9). 3557–3565. 52 indexed citations

14.

Kitange, Gaspar J., Thomas M. Kollmeyer, Mark E. Law, et al.. (2009). Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell‐mediated restoration of normal human chromosome 19. Genes Chromosomes and Cancer. 48(10). 854–864. 7 indexed citations

15.

Nakagawa, Tohru, Thomas M. Kollmeyer, Bruce W. Morlan, et al.. (2008). A Tissue Biomarker Panel Predicting Systemic Progression after PSA Recurrence Post-Definitive Prostate Cancer Therapy. PLoS ONE. 3(5). e2318–e2318. 135 indexed citations

16.

Yang, Ping, et al.. (2005). Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas. Cancer. 103(11). 2363–2372. 53 indexed citations

17.

Kitange, Gaspar J., Anjan Misra, Mark E. Law, et al.. (2004). Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas. Genes Chromosomes and Cancer. 42(1). 68–77. 75 indexed citations

18.

Pang, Yuan‐Ping, Thomas M. Kollmeyer, Feng Hong, et al.. (2003). Rational Design of Alkylene-Linked Bis-Pyridiniumaldoximes as Improved Acetylcholinesterase Reactivators. Chemistry & Biology. 10(6). 491–502. 86 indexed citations

19.

Hammond, P., Christian Kern, Feng Hong, et al.. (2003). Cholinesterase Reactivation in Vivo with a Novel Bis-Oxime Optimized by Computer-Aided Design. Journal of Pharmacology and Experimental Therapeutics. 307(1). 190–196. 30 indexed citations

20.

Pang, Yuan‐Ping, Kun Xu, Thomas M. Kollmeyer, et al.. (2001). Discovery of a new inhibitor lead of adenovirus proteinase: steps toward selective, irreversible inhibitors of cysteine proteinases. FEBS Letters. 502(3). 93–97. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact